To determine if somatic mutations identified in human tumor samples directly affected this critical interaction between ATG5 and ATG16L1, we next compiled a list of all somatic ATG5 coding-sequence mutations that have been identified across a multitude of human tumors and cancer cell lines (Supplementary Table S1). This evidence concerns the gene ATG16L1 and neoplasm.